Article
Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Jul 2012
Brown Jennifer R, Hanna Megan, Tesar Bethany, Werner Lillian, Pochet Nathalie, Asara John M, Wang Yaoyu E, Dal Cin Paola, Fernandes Stacey M, Thompson Christina, Macconaill Laura, Wu Catherine J, Van de Peer Yves, Correll Mick, Regev Aviv, Neuberg Donna, Freedman Arnold S
Abstract excerpt
PURPOSE: The disease course of chronic lymphocytic leukemia (CLL) varies significantly within cytogenetic groups. We hypothesized that high-resolution genomic analysis of CLL would identify additional recurrent abnormalities associated with short time-to-first therapy (TTFT). EXPERIMENTAL DESIGN: We undertook high-resolution genomic analysis of 161 prospectively enrolled CLLs using Affymetrix 6.0 SNP arrays, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
